• Partner links

  • Using Antiretrovirals To Prevent HIV Infections – World Health Organization

    Editor’s ChoiceMain Category: HIV / AIDSArticle Date: 21 Jul 2012 – 7:00 PDT

    Current ratings for:Using Antiretrovirals To Prevent HIV Infections – World Health Organization

    not yet rated1 star

    The World Health Organization (WHO) has issued its first guidance to nations considering providing ARVs (antiretrovirals) to HIV-negative, high risk people. HIV is a retrovirus. Retroviruses are composed of RNA, not DNA; they have an enzyme (reverse transcriptase) which grants them to transcribe their RNA into DNA after getting into a cell, the retroviral DNA can then become an integral part of the host cell’s chromosomal DNA. Antiretrovirals are medications used to manage or control infections caused by retroviruses.PrEP (Pre-exposure prophylaxis)WHO states its recommendations were based on human trials which showed that administering PrEP (pre-exposure prophylaxis) once daily to HIV-negative individuals who are at high risk of becoming infected, is both safe and effective in helping prevent HIV infection.

    Clinical trial results showed that PrEP usage can lower HIV infection rates by approximately 40% among men who have sex with men. Patients who took the drug regularly had a 73% lower risk. Among couples where one of them is HIV positive who regularly took PreP, the reduction in risk was 75%.

    WHO emphasized that PrEP usage must be accompanied by safe sex practices – consistent use of condoms – as well as regular testing for HIV, getting prompt treatment for STIs (sexually transmitted infection), and counseling.

    For PrEP to work properly, adherence is vital – people need to take the medications every day. This may not be simple to achieve, WHO added. The next challenge is to find ways of delivering PrEP in “real life settings” in order to make sure adherence occurs. Adherence means taking the medications according to instructions, which in this case means every day.

    Setting up PrEP projects in participating countriesCountries planning to introduce PrEP are being encouraged by WHO to initially set up small projects aimed at helping public health workers fully comprehend the advantages of PrEP.

    In these initial projects, antiretroviral medications are administered to people at high risk of HIV infection. An example of a high-risk group includes males or transgender females who have sex with men. The projects need to identify who would benefit the most from PrEP, and find the ideal ways to make sure they get the medications.

    The outcomes of these projects would be evaluated by WHO, which would contribute towards WHO guidelines on antiretroviral usage for the prevention and treatment of HIV infection. WHO plans to issue the guidelines in the middle of next year.

    TruvadaTruvada, a once-daily oral drug – is a combination of tenofovir disoproxil fumarate and emtricitabine.

    Truvada is produced and marketed by Gilead Sciences.

    Written by Christian NordqvistCopyright: Medical News TodayNot to be reproduced without permission of Medical News Today

    Visit our hiv / aids section for the latest news on this subject. Please use one of the following formats to cite this article in your essay, paper or report:

    Please note: If no author information is provided, the source is cited instead.

    Add Your Opinion On This Article’Using Antiretrovirals To Prevent HIV Infections – World Health Organization’

    Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

    If you write about specific medications or operations, please do not name health care professionals by name.

    All opinions are moderated before being included (to stop spam)

    For any corrections of factual information, or to contact the editors please use our feedback form.Please send any medical news or health news press releases to:

    Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

    Related News:


    Details :
    Submited at Saturday, July 21st, 2012 at 4:15 pm on Uncategorized by jessica
    Comment RSS 2.0 - leave a comment - trackback

    Warning: Unknown: write failed: Disk quota exceeded (122) in Unknown on line 0

    Warning: Unknown: Failed to write session data (files). Please verify that the current setting of session.save_path is correct (/tmp) in Unknown on line 0